Board

Other Board Members

Charles Goff

Managing Director, New Capital Fund

Mr. Goff holds a degree in Math and Computer Science from the University of Wisconsin-Oshkosh and an MBA from the University of Wisconsin-Madison. He began his career with in accounting with Arthur Andersen where he participated in a wide range of consulting engagements. He later founded Forward Enterprises, Inc., a distributor of industrial piping products to the pulp and paper industry. He expanded that business to five locations in three states and $30 million in revenue prior to selling it to Ferguson Enterprises where he became the General Manager of their Northeast Wisconsin Division. Mr. Goff became president of the New Capital Management in 2006 and has acted as the General Partner of The New Capital Fund. He serves on the board of several of the companies in which New Capital has invested.

Jason Smith

President, Peak Ridge Capital

In addition to his role as President of Peak Ridge Capital, Mr. Smith is a member of the firm’s Executive and Investment Committees and oversees their Midwest operations. He holds a J.D., cum laude from the New England School of Law where he was editor of the school’s academic Journal. His undergraduate degree is from the University of Wisconsin, Madison. Mr. Smith has conducted hundreds of millions of dollars of private investment transactions and serves on the boards of many of the companies Peak Ridge Capital has invested in.

Erik Rutten

Senior Investment Manager, DSM Venturing

Mr. Rutten is currently Senior Investment Manager for DSM Venturing B.V., subsidiary of Royal DSM N.V., a Netherlands-based specialty performance materials and life sciences company. Mr. Rutten has been with DSM since1985, having begun his career in the Corporate Research organization heading a small explorative research department working in creating new products and new business in the polymeric material area. He has also been New Business Development Manager at DSM Special Products, head of DSM’s Custom Manufacturing new business group, and Vice President of DSM Pharmaceuticals prior to obtaining his current position as Senior Investment Manager. Mr. Rutten serves on the board of several of the companies he has funded.